Shedir Pharma Group S.p.A.

SHE

IT0005379620

Pharmaceuticals

Market Closed - Borsa Italiana Other stock markets 11:44:59 2024-04-30 am EDT			5-day change	1st Jan Change
3.78 ^EUR	-.--%		+3.85%	-16.37%

Apr. 02	Shedir Pharma, into 2023 with rising revenues; profit down single digits	AN
Mar. 29	Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Shedir Pharma Group has purchased 7,500 of its own shares

May 02, 2023 at 12:40 pm EDT

(Alliance News) - Shedir Pharma Group Spa, in connection with its share buyback program, announced that it purchased - in the period between April 24 and April 28 - a total of 7,500 of its own shares.

The average price was EUR4.935 per share, for a total consideration of EUR37,012.50.

Shedir Pharma closed Tuesday's session in the red by 4.0 percent at EUR4.78 per share.

By Maurizio Carta, Alliance News reporter

Comments and questions to redazione@alliancenews.com

Go to the original article.
Legal disclaimer

Latest news about Shedir Pharma Group S.p.A.

Shedir Pharma, into 2023 with rising revenues; profit down single digits	Apr. 02	AN
Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Shedir Pharma increases profit and revenues in the first half by double digits	23-09-29	AN
Shedir Pharma Group S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-28	CI
Milan up; Chinese bank does not touch rates	23-04-20	AN
Milan rises above 27,900; MPS bullish	23-04-19	AN
Indexes weak; TIM down after network bids	23-04-19	AN
Stock markets down ahead of Eurozone inflation	23-04-19	AN
Flat start expected in Europe, focus on results	23-04-19	AN
Milan pink jersey led by banks	23-04-18	AN
Shedir Pharma revenues rise to double digits in first quarter	23-04-18	AN
ITALY GROWTH WINNERS & LOSERS: Shedir Pharma on top; Il Fatto down	23-04-18	AN
Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-12	CI
Shedir Pharma Group S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-28	CI
Shedir Pharma Group S.p.A. commences an Equity Buyback Plan, under the authorization approved on April 29, 2022.	22-07-10	CI
Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-28	CI
Shedir Pharma Group S.P.A. Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-28	CI
Certain Shares of Shedir Pharma Group S.p.A. are subject to a Lock-Up Agreement Ending on 24-JUL-2021.	21-07-23	CI
Shedir Pharma Group S.P.A. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-28	CI
400,000 Shares of Shedir Pharma Group S.p.A. are subject to a Lock-Up Agreement Ending on 31-DEC-2019.	19-12-30	CI
Shedir Pharma Group S.p.A. has completed an IPO in the amount of €9.9995 million.	19-07-17	CI

Chart Shedir Pharma Group S.p.A.

Duration

Period

More charts

Company Profile

Shedir Pharma Srl is an Italy-based pharmaceutical company specialized in nutraceuticals, cosmetics and medical devices. The Company markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.78 EUR

Average target price

8.08 EUR

Spread / Average Target

+113.76%

Consensus

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SHEDIR PHARMA GROUP S.P.A.	-16.37%	45.93M
ELI LILLY AND COMPANY	+33.25%	704B
NOVO NORDISK A/S	+28.59%	577B
JOHNSON & JOHNSON	-3.55%	348B
MERCK & CO., INC.	+18.16%	327B
ABBVIE INC.	+4.36%	288B
ASTRAZENECA PLC	+14.81%	234B
NOVARTIS AG	+4.93%	198B
ROCHE HOLDING AG	-9.78%	194B
AMGEN INC.	-3.69%	147B

Other Pharmaceuticals

Shedir Pharma Group S.p.A.

Equities

SHE

IT0005379620

Pharmaceuticals

Shedir Pharma Group has purchased 7,500 of its own shares

Latest news about Shedir Pharma Group S.p.A.

Chart Shedir Pharma Group S.p.A.

Company Profile

Income Statement Evolution

Analysts' Consensus

Annual profits - Rate of surprise

Sector Other Pharmaceuticals